Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Income from Non-Controlling Interests (2020 - 2026)

Tilray Brands' (TLRY) quarterly Income from Non-Controlling Interests came in at $12.3 million in Q2 2026, up 150.94% YoY from $4.9 million in Q2 2025, and up 689.72% on a QoQ basis from $1.6 million in Q1 2026.

Tilray Brands (TLRY) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 7 years of Income from Non-Controlling Interests data on file, last reported at $12.3 million in Q2 2026.

  • Quarterly Income from Non-Controlling Interests rose 150.94% year-over-year to $12.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $17.6 million (up 281.51% YoY) and the FY2026 annual result came in at $17.6 million, up 227.31% from the prior year.
  • Income from Non-Controlling Interests grew to $12.3 million in Q2 2026, from $1.6 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $20.3 million in Q2 2022 to a low of -$24.8 million in Q1 2023.
  • A 5-year average of $4.6 million and a median of $5.0 million in 2024 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 402.74% — and 2023, when it sank 366.6%.
  • Tracing TLRY's Income from Non-Controlling Interests over 5 years: stood at $7.8 million in 2022, then slumped by 63.8% to $2.8 million in 2023, then tumbled by 128.9% to -$819000.0 in 2024, then surged by 337.97% to $1.9 million in 2025, then surged by 530.89% to $12.3 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $12.3 million (Q2 2026), $1.6 million (Q1 2026), and $1.9 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn 12.30 Mn

Historic Data

Download Data
DateValue
May 31, 2026 12.30 Mn
Feb 28, 2026 1.56 Mn
Nov 30, 2025 1.95 Mn
Aug 31, 2025 1.84 Mn
May 31, 2025 4.90 Mn
Feb 28, 2025 -4.51 Mn
Nov 30, 2024 -819,000.00
Aug 31, 2024 5.05 Mn
May 31, 2024 16.09 Mn
Feb 29, 2024 -12.28 Mn
Nov 30, 2023 2.83 Mn
Aug 31, 2023 15.82 Mn
May 31, 2023 17.52 Mn
Feb 28, 2023 -24.75 Mn
Nov 30, 2022 7.83 Mn
Aug 31, 2022 7.69 Mn
May 31, 2022 20.34 Mn
Feb 28, 2022 9.29 Mn
Nov 30, 2021 6.00 Mn
Aug 31, 2021 7.05 Mn